PARAMETRIC PORTFOLIO ASSOCIATES LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 217 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$2,233,000
+71.8%
62,426
+24.9%
0.01%
+66.7%
Q3 2014$1,300,000
+124.1%
49,991
+184.7%
0.00%
+200.0%
Q2 2014$580,000
-25.4%
17,561
-32.3%
0.00%
-50.0%
Q1 2014$777,000
-9.8%
25,949
-8.5%
0.00%0.0%
Q4 2013$861,000
-38.6%
28,351
-35.7%
0.00%
-50.0%
Q3 2013$1,403,000
+89.9%
44,091
-9.8%
0.00%
+100.0%
Q2 2013$739,00048,9020.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders